Monday, September 2, 2013

Health News: [diabetes ]: Mixed safety report for diabetes pills: DPP-4 therapies didn’t raise risk of heart of attack but could be linked to ...

Yahoo! Health   |  My alerts   |   Edit Alert
Monday, Sep 02, 2013 04:11 PM EDT
 
   Health News : diabetes - News from other sources.
 
Mixed safety report for diabetes pills: DPP-4 therapies didn't raise risk of heart of attack but could be linked to ...
Mon, 02 Sep, 2013 10:09 AM PDT
AMSTERDAM (Reuters) - Diabetes pills known as DPP-4 therapies got a mixed safety report on Monday as studies showed they did not raise the risk of heart attacks but might be linked to heart failure, where the heart fails to pump blood adequately. Reas...
Continue reading
Treatment with the anti-diabetic drug alogliptin does not increase CV risk in patients with ACS
Mon, 02 Sep, 2013 10:08 AM PDT
Patients with Type 2 diabetes and high cardiovascular risk due to recent acute coronary syndromes had similar rates of cardiovascular events when treated with the anti-diabetic agent alogliptin compared to placebo according to new results.
Continue reading
In Vitro Diagnostics Market Will Reach USD 1.1 Billion by 2018 : Transparency Market Research
Mon, 02 Sep, 2013 09:43 AM PDT
Transparency Market Research Published new "In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics)- Global Industry Analysis, Size, Share, Growth and Forecast, 2012 – 2018" market research report to its report store. Browse the report with ...
Continue reading
Novo Nordisk to bring in next-gen insulin Tresiba
Mon, 02 Sep, 2013 09:38 AM PDT
Denmark headquartered Novo Nordisk is set to bring in its "designer insulin" that reduces the risk of low blood sugar at night, a key concern for people with diabetes, who take insulin. ...
Continue reading
You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.

No comments:

Post a Comment